Long-term risk of cardiovascular disease after assisted reproductive technology and infertility: A cohort study
PLOS Medicine · 12.08.2026 · 23 (8) · e1005120
DOI: 10.1371/journal.pmed.1005120 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS Medicine, online erschienen am 12.08.2026. Verfasst von Angelo Giosuè Mezzoiuso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Cardiovascular Diseases, Infertility, Female. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Forte – Swedish Research Council for Health, Working Life and Welfare, Stiftelsen Riksbankens Jubileumsfond, Karolinska Institutet.
Abstract (Originalsprache)
Background
The use of Assisted Reproductive Technology (ART) is increasing worldwide. These treatments involve ovarian stimulation to enable multiple follicle recruitment, hence inducing supraphysiological estrogen levels. While most long-term follow-up of women undergoing ART has concerned cancer incidence, the long-term safety regarding cardiovascular and metabolic diseases remains under-explored. This study was performed to assess the risk of acute myocardial infarction, cerebral ischemic conditions, intracranial hemorrhage, type 2 diabetes mellitus, heart failure, aortic aneurysm or dissection, and chronic kidney disease in women that conceived with ART, and to investigate the role of the underlying infertility and its risk factors. Methods and findings Swedish national registers allowed us to follow a nationwide cohort of 380,756 women from their first birth between 1992 and 2002 until the end of 2023. The safety of ART was evaluated by comparing women with infertility who conceived with and without ART, while adjusting for baseline differences in age, body mass index, country of origin, socioeconomic factors, pre-existing comorbidity, smoking and year. The role of infertility was additionally explored by comparing all women with and without infertility adjusting for age, as well as the aforementioned baseline characteristics. Cumulative risks were plotted using inverse-probability weighted Kaplan-Meier curves. To facilitate the comparison of groups, we also estimated risk differences and ratios at 10-, 20-, and 30 years of follow-up. Use of ART was not associated with cardiovascular disease except for an excess risk of cerebral ischemic conditions, with a 30-year risk ratio of 1.44 (95% Confidence Interval (CI) [1.09,1.90]). With the exception of cerebral ischemic conditions, intracranial hemorrhage, aortic dissection, and chronic kidney disease, women with a history of infertility exhibited consistently higher risk of all outcomes, and adjustment for differences in baseline characteristics explained some but not all of these elevated risks. Even though the study period was restricted with respect to the earliest years of ART implementation, the number of exposed was still low and risks calculated with limited precision, particularly at the beginning and at the end of the follow-up due to very few events and decreasing numbers at risk, respectively.
Conclusions
With the exception of ischemic cerebral conditions, the findings provide reassurance regarding the long-term cardiometabolic safety of ART use, while adding to the growing literature suggesting that infertility can act as a marker of women’s cardiovascular and metabolic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
- Centre Urbanisation Culture Société, Institut National de la Recherche Scientifique, Montréal, Quebec, Canada.
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
ORCID-Profile: Angelo Giosuè Mezzoiuso, Peter Henriksson, Kenny A Rodriguez-Wallberg, Anna Sara Oberg
Förderung
- Forte – Swedish Research Council for Health, Working Life and Welfare
- Stiftelsen Riksbankens Jubileumsfond
- Karolinska Institutet
- Swedish Cancer Society
- Radiumhemmets Research Funds for clinical researchers
Zitieren
APA
Mezzoiuso, A. G., Henriksson, P., Radó, M., Rodriguez-Wallberg, K. A., & Oberg, A. S. (2026). Long-term risk of cardiovascular disease after assisted reproductive technology and infertility: A cohort study. PLOS Medicine, 23(8), e1005120. https://doi.org/10.1371/journal.pmed.1005120
Vancouver
Mezzoiuso AG, Henriksson P, Radó M, Rodriguez-Wallberg KA, Oberg AS. Long-term risk of cardiovascular disease after assisted reproductive technology and infertility: A cohort study. PLOS Medicine. 2026;23(8):e1005120. doi:10.1371/journal.pmed.1005120
BibTeX
@article{Mezzoiuso2026,
author = {Mezzoiuso, Angelo Giosuè and Henriksson, Peter and Radó, Márta and Rodriguez-Wallberg, Kenny A and Oberg, Anna Sara},
title = {Long-term risk of cardiovascular disease after assisted reproductive technology and infertility: A cohort study},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {8},
pages = {e1005120},
doi = {10.1371/journal.pmed.1005120}
}
EUVIMED